ArticleNPJ digital medicine2026
Real-time AI-assisted quality control during nasopharyngolaryngoscopy: a randomized controlled trial.
Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Nasopharyngolaryngoscopy (NPL) is widely used to examine the nasopharyngolaryngeal anatomical sites. The quality of NPL depends on the endoscopist's performance, and incomplete examinations may contribute to missed findings in practice. Here, we developed ENDOVISTA-ENT, an intelligent quality control system trained on NPL videos from 3,630 patients. The system can monitor anatomical coverage in real time during NPL procedures. It is not designed to detect lesions. By integrating into the existing NPL workflow, it provides endoscopists with real-time feedback on anatomical coverage, examination progress, and procedure duration. To evaluate its effect, we conducted a prospective, double-centre, randomized controlled trial registered in the Chinese Clinical Trial Registry (ChiCTR2400091245). A total of 318 patients were randomly assigned to undergo ENDOVISTA-ENT-assisted or conventional NPL examination. The primary outcome was coverage of predefined anatomical sites. Results showed that ENDOVISTA-ENT-assisted NPL examinations achieved signi6cantly higher mean anatomical coverage than conventional examinations (93.08% vs. 83.50%, P < 0.0001). Importantly, this improvement occurred without significantly increasing examination time. Subgroup analyses revealed benefits across all experience levels, particularly among junior endoscopists. These findings suggest that a real-time AI-assisted quality control system can support a more standardized NPL workflow and improve endoscopists' procedural completeness during NPL.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.